 |
|
Urine myo-inositol as a novel prognostic biomarker for diabetic kidney disease: a targeted metabolomics study using nuclear magnetic resonance
Soie Kwon, Jin Seong Hyeon (Hyeon 1), Youngae Jung, Lilin Li, Jung Nam An, Yong Chul Kim, Seung Hee Yang, Tammy Kim, Dong Ki Kim, Chun Soo Lim, Geum-Sook Hwang, Jung Pyo Lee
Kidney Res Clin Pract. 2023;42(4):445-459. Published online 2023 Jul 25 DOI: https://doi.org/10.23876/j.krcp.22.152
|
|
Citations to this article as recorded by
 Metabolomic Applications in Gut Microbiota-Host Interactions in Human Diseases
Yuxin Li, Shuo Han
Gastroenterology Clinics of North America.2024;[Epub] CrossRef Development of Serum Lactate Level-Based Nomograms for Predicting Diabetic Kidney Disease in Type 2 Diabetes Mellitus Patients
Chunxia Jiang, Xiumei Ma, Jiao Chen, Yan Zeng, Man Guo, Xiaozhen Tan, Yuping Wang, Peng Wang, Pijun Yan, Yi Lei, Yang Long, Betty Yuen Kwan Law, Yong Xu
Diabetes, Metabolic Syndrome and Obesity.2024; Volume 17: 1051. CrossRef Virtual diagnosis of diabetic nephropathy using metabolomics in place of kidney biopsy: The DIAMOND study
Da Woon Kim, Hyo Jin Kim, Eun Young Seong, Sang Soo Kim, Sujin Lee, Suhkmann Kim, Chae Hwa Kwon, Sang Heon Song
Diabetes Research and Clinical Practice.2023; 205: 110986. CrossRef CKD Urine Metabolomics: Modern Concepts and Approaches
Elena Y. Danilova, Anna O. Maslova, Andrey N. Stavrianidi, Alexander E. Nosyrev, Larisa D. Maltseva, Olga L. Morozova
Pathophysiology.2023; 30(4): 443. CrossRef
|